2022. Development of Solid Lipid Nanoparticles with Letrozole for Breast Cancer Treatment: in-vitro and in-vivo evaluation. Journal of Pharmaceutical Negative Results. (Sep. 2022), 1159–1166. DOI:https://doi.org/10.47750/pnr.2022.13.S01.142.